Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Peripheral vascular disease (PVD) is narrowing of arteries outside brain and heart. Risk factors for the growth of PVD include, hypertension, obesity, diabetes, and smoking. Peripheral vascular devices are used for the treatment of these blocked arteries and remove the buildup plaque. Peripheral vascular stents, peripheral transluminal angioplasty balloon catheter and aortic stents are the mostly used devices for the treatment of PVD.

Statistics:

The global peripheral vascular devices market is estimated to account for US$ 8,918.9 Mn in terms of value in 2020 and is expected to reach US$ 14,592.7 Mn by the end of 2027.

Global Peripheral Vascular Devices Market: Drivers

Increasing prevalence of peripheral arterial disease is expected to propel growth of the global peripheral vascular devices market over the forecast period. For instance, according to National Center for Biotechnology Information May 2018 data, over 200 million people suffer from peripheral arterial disease worldwide.

Moreover, increasing geriatric disorder is also expected to boost demand for peripheral vascular devices. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015.     

Statistics:

Peripheral Vascular Stents held dominant position in the global peripheral vascular devices market in 2019, accounting for 31.0% share in terms of value, followed by Peripheral Transluminal Angioplasty Balloon Catheters and Aortic Stents, respectively.

Figure 1. Global Peripheral Vascular Devices Market Share (%), by Value, by Product Type, 2019

Peripheral Vascular Devices  | Coherent Market Insights

Global Peripheral Vascular Devices Market: Restraints

Infection from peripheral vascular implantations is expected to hinder growth of the global peripheral vascular devices market. Insertion of foreign body has become an indispensable part in the field of medicine; however, medical devices are associated with a risk of bacterial and fungal infection. As peripheral vascular implants are in direct contact with the body, the ability for infection is more as compared to other devices.

Moreover, product recalls are expected to hinder growth of the market. For instance, in October 2019, Medtronic plc recalled all models of its 6 French Sherpa NX Active Guide Catheter because of a risk the outer material may separate from the device in fractured pieces that could be left in the patient’s bloodstream.

request-sample

Peripheral Vascular Devices Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 8,319.0 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 7.3% 2027 Value Projection: US$ 14,592.7 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Product Type: Peripheral Vascular Stents, Peripheral Transluminal Angioplasty Balloon Catheters, PTA Guidewires, Atherectomy Devices, Chronic Total Occlusion Devices, Aortic Stents, Synthetic Surgical Grafts, Embolic Protection Devices, Inferior Vena Cava Filters.
  • By End User: Hospitals, Clinics, Ambulatory Surgical Centers.
Companies covered:

Abbot Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson, and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, and Bayer AG.

Growth Drivers:
  • Technological advancement
  • Product launches
Restraints & Challenges:
  • Product recalls
  • Infection related issues

Global Peripheral Vascular Devices Market: Opportunities 

R&D in peripheral catheters is expected to offer lucrative growth opportunities for players in the global peripheral vascular devices market. For instance, in October 2019, researchers from Hartford Hospital (Hartford, Conn.) and PICC Excellence reported that implementing standardized set of best practices for inserting peripheral IV catheters results in significant clinical and economic benefits, in the Journal of the Association for Vascular Access.

Moreover, high prevalence of type 2 diabetes mellitus and hypertension is also expected to boost demand for peripheral vascular devices. For instance, in March 2019, the study ‘Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study’, reported that the prevalence of hypothyroidism in patients with type 2 diabetes mellitus, hypertension, and type 2 diabetes mellitus + hypertension was 24.8%, 33.5%, and 28.9%, respectively.   

The global peripheral vascular devices market was valued at US$ 8,319.0 Mn in 2019 and is forecast to reach a value of US$ 14,592.7 Mn by 2027 at a CAGR of 7.3% between 2020 and 2027.

Figure 2. Global Peripheral Vascular Devices Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Peripheral Vascular Devices  | Coherent Market Insights

Market Trends/Key Takeaways

Increasing awareness regarding peripheral vascular disease is expected to propel growth of the global peripheral vascular devices market. For instance, in November 2019, Brownwood Regional Medical Center and Ernesto Rivera, MD Interventional Cardiologist of Heart of Texas Heart Associates hosted a Community Education Program on Peripheral Vascular Disease and Diabetic Foot Ulcers.

Major players in the market are also focused on approval and launch of new devices to expand their product portfolio. For instance, in 2018, Teleflex Incorporated received the U.S. Food and Drug Administration (FDA) 510(k) clearance for its Expro Elite and Sympro Elite Snares for manipulating interventional devices in peripheral procedures.

Global Peripheral Vascular Devices Market: Competitive Landscape

Major players operating in the global peripheral vascular devices market include, Abbot Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., BD, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, and Bayer AG.

Global Peripheral Vascular Devices Market: Key Developments

Major players in the global peripheral vascular devices market are focused on adopting M&A strategies to expand their product portfolio. For instance, in June 2020, Becton, Dickinson and Company acquired Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease.

Peripheral vascular disease (PVD), also known as arteriosclerosis obliterans, arterial insufficiency of the legs, claudication, or intermittent claudication, is a blood circulation disorder that causes the blood vessels in the heart or brain to narrow, spasm or block. Peripheral vascular disease usually causes fatigue and pain in the legs and particularly during strenuous physical activities, which usually subsides with rest. The blood vessels supplying oxygenated blood to the arms, kidneys, intestines, and stomach are usually affected by the peripheral vascular devices. According to the Center for Disease Control and Prevention, around 12 to 20 percent of the population in the age category of 60 years and above, developed PAD, in 2016. The incidence rate of this disease is steadily increasing.

Restraints of the Global Peripheral Vascular Devices Market

Major factors hampering the growth of the peripheral vascular devices market during the forecast period constitutes of product recalls, and infection related issues.

Key features of the study:

  • This report provides in-depth analysis of the global peripheral vascular devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global peripheral vascular devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbot Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., Becton Dickinson, and Company, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, and Bayer AG.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global peripheral vascular devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Peripheral Vascular Devices Market, By Product Type:
    • Peripheral Vascular Stents
    • Peripheral Transluminal Angioplasty Balloon Catheters
    • PTA Guidewires
    • Atherectomy Devices
    • Chronic Total Occlusion Devices
    • Aortic Stents
    • Synthetic Surgical Grafts
    • Embolic Protection Devices
    • Inferior Vena Cava Filters
  • Global Peripheral Vascular Devices Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • Global Peripheral Vascular Devices Market, By Geography:
    • North America
      • By Product Type
        • Peripheral Vascular Stents
        • Peripheral Transluminal Angioplasty Balloon Catheters
        • PTA Guidewires
        • Atherectomy Devices
        • Chronic Total Occlusion Devices
        • Aortic Stents
        • Synthetic Surgical Grafts
        • Embolic Protection Devices
        • Inferior Vena Cava Filters
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type
        • Peripheral Vascular Stents
        • Peripheral Transluminal Angioplasty Balloon Catheters
        • PTA Guidewires
        • Atherectomy Devices
        • Chronic Total Occlusion Devices
        • Aortic Stents
        • Synthetic Surgical Grafts
        • Embolic Protection Devices
        • Inferior Vena Cava Filters
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Peripheral Vascular Stents
        • Peripheral Transluminal Angioplasty Balloon Catheters
        • PTA Guidewires
        • Atherectomy Devices
        • Chronic Total Occlusion Devices
        • Aortic Stents
        • Synthetic Surgical Grafts
        • Embolic Protection Devices
        • Inferior Vena Cava Filters
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type
        • Peripheral Vascular Stents
        • Peripheral Transluminal Angioplasty Balloon Catheters
        • PTA Guidewires
        • Atherectomy Devices
        • Chronic Total Occlusion Devices
        • Aortic Stents
        • Synthetic Surgical Grafts
        • Embolic Protection Devices
        • Inferior Vena Cava Filters
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Product Type
        • Peripheral Vascular Stents
        • Peripheral Transluminal Angioplasty Balloon Catheters
        • PTA Guidewires
        • Atherectomy Devices
        • Chronic Total Occlusion Devices
        • Aortic Stents
        • Synthetic Surgical Grafts
        • Embolic Protection Devices
        • Inferior Vena Cava Filters
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Peripheral Vascular Stents
        • Peripheral Transluminal Angioplasty Balloon Catheters
        • PTA Guidewires
        • Atherectomy Devices
        • Chronic Total Occlusion Devices
        • Aortic Stents
        • Synthetic Surgical Grafts
        • Embolic Protection Devices
        • Inferior Vena Cava Filters
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Abbot Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Boston Scientific Corporation
    • Angioscore
    • Emboline Inc.
    • Becton Dickinson, and Company
    • Cook Group Inc.
    • Cordis Corporation
    • Covidien PLC
    • Edward Lifesciences Corporation
    • Medtronic Plc
    • St. Jude Medical
    • Bayer AG

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis
  4. Global Peripheral Vascular Devices Market, By Product Type, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Peripheral Vascular Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Peripheral Transluminal Angioplasty Balloon Catheters
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • PTA Guidewires
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Atherectomy Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Chronic Total Occlusion Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Aortic Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Synthetic Surgical Grafts
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Embolic Protection Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Inferior Vena Cava Filters
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Peripheral Vascular Devices Market, By End User, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Peripheral Vascular Devices Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Abbot Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Angioscore
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Emboline Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Becton Dickinson, and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cook Group Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cordis Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Covidien PLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Edward Lifesciences Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medtronic Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • St. Jude Medical
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 24 figures on “Peripheral Vascular Devices Market – Global forecast to 2027.

Frequently Asked Questions

The global peripheral vascular devices market was valued at US$ 8,319.0 Mn in 2019 and is forecast to reach a value of US$ 14,592.7 Mn by 2027 at a CAGR of 7.3% between 2020 and 2027.
Major factor driving the growth of global peripheral vascular devices market during the forecast period include technological advancement, and product launches.
Major factors hampering the growth of the peripheral vascular devices market during the forecast period constitutes of product recalls, and infection related issues.
Peripheral vascular stents held dominant position in the global peripheral vascular devices market in 2019.
North America Peripheral Vascular Devices market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Abbot Laboratories, Boston Scientific Corporation, Angioscore, Emboline Inc., BD, Cook Group Inc., Cordis Corporation, Covidien PLC, Edward Lifesciences Corporation, Medtronic Plc, St. Jude Medical, and Bayer AG.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner